clinical trials have clearly demonstrated the efficacy of recombinant human erythropoietin ( r-huepo ) ( epogen [ epoetin alfa ] ; amgen inc , thousand oaks , ca ) in the treatment of the anemia associated with end-stage renal disease ( esrd ) .
C0700704
epogen
C0357126
epoetin alfa